We are a European pharmaceutical company with our own scientific research facilities. Our mission is to translate the latest scientific findings into everyday medical practice and help improve health outcomes and quality of life by marketing modern, efficacious and affordable medicines.
About us
The traditional meeting of gastroenterologists and hepatologists from all over the world will focus on the presentation of the latest scientific findings, on current topics in medical practice and, last but not least, on the sharing of professional experiences. PRO.MED.CS Praha a.s. is a proud sponsor of this event.
Read more
We’re pleased that we have been able to expand our operations, allowing us to help an ever-growing number of people around the world. During the COVID-19 pandemic we became active in Malaysia, and we are continuing to make inroads this year. Preparations are underway for the launch of our first medicinal product on the UAE market.
Read more
We are a fully integrated pharmaceutical company. We develop our own pharmaceutical dosage forms, produce medicinal products that comply with strict European standards, and take care of everything in-house – from pre-formulations, stability studies and worldwide marketing authorisations right down to the package designs. We ensure that the entire supply chain runs seamlessly so that our medicinal products always get to where they’re needed.
About us
Our goal is to care for and protect people’s health. This is why we focus all of our efforts on developing and producing high-quality medicinal products. We are continuously searching for new solutions that will help improve health outcomes and quality of life around the world.
With longstanding investments into research and innovation, we support research teams and independent laboratories in the search for new active substances and treatments.
Partnership & Research
The products in our broad portfolio primarily help in treating gastrointestinal tract diseases, but we also place significant focus on diseases of the cardiovascular and central nervous systems. Our current annual production volume exceeds one billion tablets, coated tablets and capsules. All of our products comply with strict pharmaceutical manufacturing standards in more than thirty countries worldwide where we operate.
See portfolio
The traditional meeting of gastroenterologists and hepatologists from all over the world will focus on the presentation of the latest scientific findings, on current topics in medical practice and, last but not least, on the sharing of professional experiences. PRO.MED.CS Praha a.s. is a proud sponsor of this event.
We have started preparing for next year’s 13th International Symposium of Gastroenterology (ISG). Istanbul, the largest city of Turkey, will host the event. This now regular meeting of gastroenterologists and hepatologists from around the world will focus on presenting the latest scientific findings, current topics in medical practice and, lastly but importantly, sharing professional experience.
We’re pleased that we have been able to expand our operations, allowing us to help an ever-growing number of people around the world. During the COVID-19 pandemic we became active in Malaysia, and we are continuing to make inroads this year. Preparations are underway for the launch of our first medicinal product on the UAE market.
We are continually expanding our team and hiring professionals in a variety of fields. Perhaps you’re just the one we’re looking for!
Work for us